Ország: Ausztrália
Nyelv: angol
Forrás: Department of Health (Therapeutic Goods Administration)
drospirenone, Quantity: 3 mg; ethinylestradiol, Quantity: 20 microgram
Lupin Australia Pty Limited
Tablet, film coated
Excipient Ingredients: pregelatinised maize starch; lactose monohydrate; magnesium stearate; maize starch; titanium dioxide; hypromellose; macrogol 400
Oral
2 x 28 tablets, 6 x 28 tablets, 3 x 28 tablets, 4 x 28 tablets, 1 x 28 tablets
(S4) Prescription Only Medicine
Ethinylestradiol/ Drospirenone tablet is indicated for use as:,?an oral contraceptive.,?treatment of symptoms of premenstrual dysphoric disorder (PMDD) in women who have chosen oral contraceptives as their method of birth control. The efficacy of Ethinylestradiol/ Drospirenone tablet for PMDD was not assessed beyond 3 cycles. Ethinylestradiol/ Drospirenone tablet has not been evaluated for treatment of PMS (premenstrual syndrome).
Visual Identification: White to off-white round, biconvex film coated tablets, plain on both the sides.; Container Type: Blister Pack; Container Material: PVC/PCTFE (Aclar)/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius
Registered
2020-09-11